Glucocorticoid-induced leucine zipper (GILZ) inhibits B cell activation in systemic lupus erythematosus

Annals of the Rheumatic Diseases

Volumn 75, Issue 4, 2016, Pages 739-747

  Jones, Sarah A ^a   Toh, Andrew E J ^a   Odobasic, Dragana ^a   Oudin, Marie Anne Virginie ^a   Cheng, Qiang ^a   Lee, Jacinta P W ^a   White, Stefan J ^b   Russ, Brendan E ^c   Infantino, Simona ^c,d   Light, Amanda ^c,d   Tarlinton, David M ^c,d   Harris, James ^a   Morand, Eric F ^a  

^a MONASH UNIVERSITY   (Australia)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID INDUCED LEUCINE ZIPPER; HEMOCYANIN; HYBRID PROTEIN; LEUCINE ZIPPER PROTEIN; NITROPHENOL; UNCLASSIFIED DRUG; DSIP1 PROTEIN, MOUSE; GLUCOCORTICOID; HISTONE; IMMUNOLOGICAL ADJUVANT; KEYHOLE-LIMPET HEMOCYANIN; TRANSCRIPTION FACTOR; TSC22D3 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE ACTIVITY; DOWN REGULATION; GENE EXPRESSION; GERMINAL CENTER; HUMAN; HUMAN CELL; IMMUNIZATION; IN VITRO STUDY; MEMORY CELL; MONONUCLEAR CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MALE; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; UPREGULATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; AUTOIMMUNITY; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; GENE EXPRESSION REGULATION; GERMINAL CENTER; GLUCOCORTICOIDS; HEMOCYANIN; HISTONES; IN VITRO TECHNIQUES; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, KNOCKOUT; NITROPHENOLS; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84961950212     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2015-207744     Document Type: Article

References (71)

1. Bruce IN, O'Keeffe AG, Farewell V, et al. Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort. Ann Rheum Dis 2015;74:1706-13.
2. Ruiz-Arruza I, Ugarte A, Cabezas-Rodriguez I, et al. Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2014;53:1470-6.
3. Fan H, Morand EF. Targeting the side effects of steroid therapy in autoimmune diseases: the role of GILZ. Discov Med 2012;13:123-33.
4. Beaulieu E, Morand EF. Role of GILZ in immune regulation, glucocorticoid actions and rheumatoid arthritis. Nat Rev Rheumatol 2011;7:340-8.
5. Haneda M, Owaki M, Kuzuya T, et al. Comparative analysis of drug action on B-cell proliferation and differentiation for mycophenolic acid, everolimus, and prednisolone. Transplantation 2014;97:405-12.
6. Voetberg BJ, Garvy BA, Mayer HK, et al. Apoptosis accompanies a change in the phenotypic distribution and functional capacity of murine bone marrow B-cells chronically exposed to prednisolone. Clin Immunol Immunopathol 1994;71:190-8.
7. Garvy BA, King LE, Telford WG, et al. Chronic elevation of plasma corticosterone causes reductions in the number of cycling cells of the B lineage in murine bone marrow and induces apoptosis. Immunology 1993;80:587-92.
8. Surjit M, Ganti KP, Mukherji A, et al. Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 2011;145:224-41.
9. Beaulieu E, Ngo D, Santos L, et al. Glucocorticoid-induced leucine zipper is an endogenous antiinflammatory mediator in arthritis. Arthritis Rheum 2010;62:2651-61.
10. Lekva T, Bollerslev J, Kristo C, et al. The Glucocorticoid-Induced Leucine Zipper Gene (GILZ) Expression Decreases after Successful Treatment of Patients with Endogenous Cushing's Syndrome and May Play a Role in Glucocorticoid-Induced Osteoporosis. J Clin Endocrinol Metab. 2010;95:246-55.
11. Mittelstadt PR, Ashwell JD. Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ. J Biol Chem 2001;276:29603-10.
12. Di Marco B, Massetti M, Bruscoli S, et al. Glucocorticoid-induced leucine zipper (GILZ)/NF-kappaB interaction: role of GILZ homo-dimerization and C-terminal domain. Nucleic Acids Res 2007;35:517-28.
13. Cannarile L, Fallarino F, Agostini M, et al. Increased GILZ expression in transgenic mice up-regulates Th-2 lymphokines. Blood 2006;107:1039-47.
14. Delfino DV, Agostini M, Spinicelli S, et al. Decrease of Bcl-xL and augmentation of thymocyte apoptosis in GILZ overexpressing transgenic mice. Blood 2004;104:4134-41.
15. Ayroldi E, Petrillo MG, Bastianelli A, et al. L-GILZ binds p53 and MDM2 and suppresses tumor growth through p53 activation in human cancer cells. Cell Death Differ 2015;22:118-30.
16. Fan H, Kao W, Yang YH, et al. Macrophage Migration Inhibitory Factor Inhibits the Antiinflammatory Effects of Glucocorticoids via Glucocorticoid-Induced Leucine Zipper. Arthritis Rheum 2014;66:2059-70.
17. Cheng Q, Fan H, Ngo D, et al. GILZ overexpression inhibits endothelial cell adhesive function through regulation of NF-kappaB and MAPK activity. J Immunol 2013;191:424-33.
18. Yosef N, Shalek AK, Gaublomme JT, et al. Dynamic regulatory network controlling TH17 cell differentiation. Nature 2013;496:461-8.
19. Lim W, Park C, Shim MK, et al. Glucocorticoids suppress hypoxia-induced COX-2 and hypoxia inducible factor-1alpha expression through the induction of glucocorticoid-induced leucine zipper. Br J Pharmacol 2014;171:735-45.
20. Hamdi H, Godot V, Maillot MC, et al. Induction of antigen-specific regulatory T lymphocytes by human dendritic cells expressing the glucocorticoid-induced leucine zipper. Blood 2007;110:211-19.
21. Cohen N, Mouly E, Hamdi H, et al. GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response. Blood 2006;107:2037-44.
22. Cannarile L, Cuzzocrea S, Santucci L, et al. Glucocorticoid-induced leucine zipper is protective in Th1-mediated models of colitis. Gastroenterology 2009;136:530-41.
23. Berrebi D, Bruscoli S, Cohen N, et al. Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. Blood 2003;101:729-38.
24. Cheng Q, Fan H, Ngo D, et al. GILZ overexpression inhibits endothelial cell adhesive function through regulation of NF-κB and MAPK activity. J Immunol 2013;191:424-33.
25. Ngo D, Beaulieu E, Gu R, et al. Divergent effects of endogenous and exogenous GILZ in models of inflammation and arthritis. Arthritis Rheum 2013;65:1203-12.
26. Bruscoli S, Biagioli M, Sorcini D, et al. Lack of Glucocorticoid-induced leucine zipper (GILZ) deregulates B cell survival and results in B cell lymphocytosis in mice. Blood 2015;126:1790-801.
27. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
28. Golder V, Connelly K, Staples M, et al. Association of Asian ethnicity with disease activity in SLE: an observational study from the Monash Lupus Clinic. Lupus 2013;22:1425-30.
29. Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002;29:288-91.
30. Gladman DD, Goldsmith CH, Urowitz MB, et al. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol 2000;27:373-6.
31. Ngo D, Cheng Q, O'Connor AE, et al. Glucocorticoid-Induced Leucine Zipper (GILZ) regulates testicular FOXO1 activity and spermatogonial stem cell (SSC) function. PLoS ONE 2013;8:e59149.
32. Hibbs ML, Tarlinton DM, Armes J, et al. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 1995;83:301-11.
33. Tsantikos E, Oracki SA, Quilici C, et al. Autoimmune disease in Lyn-deficient mice is dependent on an inflammatory environment established by IL-6. J Immunol 2010;184:1348-60.
34. Jones SA, White CA, Robb L, et al. SOCS3 deletion in B cells alters cytokine responses and germinal center output. J Immunol 2011;187:6318-26.
35. Oracki SA, Tsantikos E, Quilici C, et al. CTLA4Ig alters the course of autoimmune disease development in Lyn-/-mice. J Immunol 2010;184:757-63.
36. Odobasic D, Muljadi RC, O'Sullivan KM, et al. Suppression of Autoimmunity and Renal Disease in Pristane-Induced Lupus by Myeloperoxidase. Arthritis Rheumatol 2015;67:1868-80.
37. Zhang K, Kagan D, DuBois W, et al. Mndal, a new interferon-inducible family member, is highly polymorphic, suppresses cell growth, and may modify plasmacytoma susceptibility. Blood 2009;114:2952-60.
38. Brune V, Tiacci E, Pfeil I, et al. Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. J Exp Med 2008;205:2251-68.
39. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) Method. Methods 2001;25:402-8.
40. Zhang J, Jima D, Moffitt AB, et al. The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells. Blood 2014;123:2988-96.
41. Heinz S, Benner C, Spann N, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 2010;38:576-89.
42. Kent WJ, Sugnet CW, Furey TS, et al. The human genome browser at UCSC. Genome Res 2002;12:996-1006.
43. Choi JM, Shin JH, Sohn MH, et al. Cell-permeable Foxp3 protein alleviates autoimmune disease associated with inflammatory bowel disease and allergic airway inflammation. Proc Natl Acad Sci USA 2010;107:18575-80.
44. Liu S, Tobias R, McClure S, et al. Removal of endotoxin from recombinant protein preparations. Clin Biochem 1997;30:455-63.
45. Jacobi AM, Mei H, Hoyer BF, et al. HLA-DRhigh/CD27high plasmablasts indicate active disease in patients with systemic lupus erythematosus. Ann Rheum Dis 2010;69:305-8.
46. Boekel ET, Prins M, Vrielink GJ, et al. Longitudinal studies of the association between peripheral CD27++ plasma cells and systemic lupus erythematosus disease activity: preliminary results. Ann Rheum Dis 2011;70:1341-2.
47. Kelly MM, King EM, Rider CF, et al. Corticosteroid-induced gene expression in allergen-challenged asthmatic subjects taking inhaled budesonide. Br J Pharmacol 2012;165:1737-47.
48. Soundararajan R, Wang J, Melters D, et al. Differential activities of glucocorticoid-induced leucine zipper protein isoforms. J Biol Chem 2007;282:36303-13.
49. Odendahl M, Jacobi A, Hansen A, et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol 2000;165:5970-9.
50. Cupps TR, Edgar LC, Thomas CA, et al. Multiple mechanisms of B cell immunoregulation in man after administration of in vivo corticosteroids. J Immunol 1984;132:170-5.
51. Li X, Zhang FS, Zhang JH, et al. Negative relationship between expression of glucocorticoid receptor alpha and disease activity: glucocorticoid treatment of patients with systemic lupus erythematosus. J Rheumatol 2010;37:316-21.
52. Macedo JA, Hesse J, Turner JD, et al. Glucocorticoid sensitivity in fibromyalgia patients: decreased expression of corticosteroid receptors and glucocorticoid-induced leucine zipper. Psychoneuroendocrinology 2008;33:799-809.
53. Yokoyama T, Tanahashi M, Kobayashi Y, et al. The expression of Bcl-2 family proteins (Bcl-2, Bcl-x, Bax, Bak and Bim) in human lymphocytes. Immunol Lett 2002;81:107-13.
54. Martinez-Valdez H, Guret C, de Bouteiller O, et al. Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2. J Exp Med 1996;183:971-7.
55. Zhou P, Qian L, Bieszczad CK, et al. Mcl-1 in transgenic mice promotes survival in a spectrum of hematopoietic cell types and immortalization in the myeloid lineage. Blood 1998;92:3226-39.
56. Vikstrom I, Carotta S, Lüthje K, et al. Mcl-1 is essential for germinal center formation and B cell memory. Science 2010;330:1095-9.
57. Pan L, Sato S, Frederick JP, et al. Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene. Mol Cell Biol 1999;19:5969-80.
58. Hou B, Saudan P, Ott G, et al. Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response. Immunity 2011;34:375-84.
59. Turqueti-Neves A, Otte M, Prazeres da Costa O, et al. B-cell-intrinsic STAT6 signaling controls germinal center formation. Eur J Immunol 2014;44:2130-8.
60. Rookhuizen DC, DeFranco AL. Toll-like receptor 9 signaling acts on multiple elements of the germinal center to enhance antibody responses. Proc Natl Acad Sci USA 2014;111:E3224-3233.
61. Cunninghame Graham DS, Manku H, Wagner S, et al. Association of IRF5 in UK SLE families identifies a variant involved in polyadenylation. Hum Mol Genet 2007;16:579-91.
62. Graham RR, Kyogoku C, Sigurdsson S, et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci USA 2007;104:6758-63.
63. Arasappan D, Tong W, Mummaneni P, et al. Meta-analysis of microarray data using a pathway-based approach identifies a 37-gene expression signature for systemic lupus erythematosus in human peripheral blood mononuclear cells. BMC Med 2011;9:65.
64. Nikpour M, Dempsey AA, Urowitz MB, et al. Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus. Ann Rheum Dis 2008;67:1069-75.
65. Oracki SA, Walker JA, Hibbs ML, et al. Plasma cell development and survival. Immunol Rev 2010;237:140-59.
66. Tarlinton DM. Evolution in miniature: selection, survival and distribution of antigen reactive cells in the germinal centre. Immunol Cell Biol 2008;86:133-8.
67. Bessa J, Kopf M, Bachmann MF. Cutting edge: IL-21 and TLR signaling regulate germinal center responses in a B cell-intrinsic manner. J Immunol 2010;184:4615-19.
68. Soni C, Wong EB, Domeier PP, et al. B cell-intrinsic TLR7 signaling is essential for the development of spontaneous germinal centers. J Immunol 2014;193:4400-14.
69. Guiducci C, Gong M, Xu Z, et al. TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus. Nature 2010;465:937-41.
70. Luz-Crawford P, Tejedor G, Mausset-Bonnefont AL, et al. Glucocorticoid-induced leucine zipper governs the therapeutic potential of mesenchymal stem cells by inducing a switch from pathogenic to regulatory Th17 cells in a mouse model of collagen-induced arthritis. Arthritis Rheumatol 2015;67:1514-24.
71. Jones SA, Perera DN, Fan H, et al. GILZ regulates Th17 responses and restrains IL-17-mediated skin inflammation. J Autoimmun 2015;61:73-80.